Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Pimblett Emily | Sep 20, 2024 | Sell | 1,182 | $8.18 | $9,700 |
| Pimblett Emily | Sep 20, 2024 | Sell | 9 | $8.06 | $73 |
| Morisset Valerie | Jul 22, 2024 | Sell | 39,005 | $8.07 | $310,000 |
| Morisset Valerie | Jul 22, 2024 | Sell | 30,000 | $7.98 | $240,000 |
| Morisset Valerie | Jul 19, 2024 | Sell | 50,000 | $7.24 | $360,000 |
| Morisset Valerie | Jul 19, 2024 | Sell | 10,201 | $7.09 | $72,000 |
| Morisset Valerie | Jul 18, 2024 | Sell | 38,576 | $6.93 | $270,000 |
| Morisset Valerie | Jul 17, 2024 | Sell | 3,207 | $6.91 | $22,000 |
| Morisset Valerie | Jul 16, 2024 | Sell | 50,000 | $7.13 | $360,000 |
| Morisset Valerie | Jul 15, 2024 | Sell | 42,377 | $7.01 | $300,000 |
| Morisset Valerie | Jul 12, 2024 | Sell | 50,000 | $7.07 | $350,000 |
| Morisset Valerie | Jul 11, 2024 | Sell | 50,000 | $7.11 | $360,000 |
| Morisset Valerie | Jul 9, 2024 | Sell | 5,931 | $6.66 | $40,000 |
| Morisset Valerie | Jul 5, 2024 | Sell | 12,342 | $7.06 | $87,000 |
| Morisset Valerie | Jul 3, 2024 | Sell | 50,000 | $6.76 | $340,000 |
| RA Capital Healthcare Fund LP | Jun 27, 2024 | Buy | 11,949,171 | $3.84 | $46M |
| RA Capital Healthcare Fund LP | Jun 27, 2024 | Buy | 1,059,375 | $3.84 | $4.1M |
| Pimblett Emily | Jun 20, 2024 | Sell | 1,245 | $7.2145 | $9,000 |
What's the latest insider transaction for Eliem Therapeutics?
The most recent insider transaction for Eliem Therapeutics was conducted by Pimblett Emily, who sold 1,182 shares on September 20, 2024 at a price of $8.18 per share.
Which insider bought the most ELYM stock over the last two years?
RA Capital Healthcare Fund LP has bought the most ELYM stock in the last 2 years, with a total value of $50M.
Which insider has sold the most ELYM stock over the last two years?
Morisset Valerie has sold the most ELYM stock in the last 2 years, with a total value of $3.1M.
What is the total value of insider transactions for Eliem Therapeutics (ELYM) in the last 2 years?
According to our estimates, the total value of insider transactions for Eliem Therapeutics in the last 2 years is positive, amounting to $47M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Eliem Therapeutics' market confidence?
Over the last 2 years, insider transactions for Eliem Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
